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Introduction
The pathologic definition of positive surgical margins (PSMs) seems 
straight forward which is considered as-‘‘a tumor extending to the 
inked surface of the prostatectomy specimen that the surgeon has cut 
across’’(1). Surgical margin status is independent of the pathological 
stage and a positive margin is not evidence of extraprostatic extension 
(2). 
Positive margins have been reported in 7.6% to 41.6% of patients 
undergoing open RP in contemporary series and have been associated 
with an increased hazard of biochemical recurrence (BCR), local 
recurrence, and the development of distant metastasis as well as the 
need for secondary cancer treatment (3,4,5).
With the widespread diffusion of prostate-specific antigen (PSA) 
testing and improvements in surgical technique, the risk of PSMs 
has been reduced considerably (6). Even so, PSM rates are associated 
with the cancer properties, surgical technique and experiences of the 
surgeon and/or pathologist. 
The aim of this multicenter study was to analyse the preoperative 
and peroperative factors predicting for PSM of 1607 patients who 
underwent radical prostatectomy (RP).
Materials and Methods
This multicenter study was performed by the Prostate Cancer Study 
Group of Turkish Association of Urooncology. Respective clinical and 
pathological findings of 1607 patients who underwent RP in 12 clinics 
in Turkey between 1993 and 2011 were assessed. All of the patients had 
clinically localized disease and thus were candidates for RP. The data 
about the age of the patient, preoperative PSA value, Gleason score 
of transrectal prostate needle biopsy, number of positive biopsy cores, 
percentage of cancer in biopsy specimens, history of transurethral 
resection of prostate (TURP), experience of the surgeon (number of 
procedures), type of surgical procedure (open, laparoscopic or robot-
assisted), utilization of nerve-sparing (NS) technique, clinical stage, 
Gleason score of RP specimen, pathological stage, status of surgical 
margin and extracapsular extention, seminal vesicle invasion, and 
lymph node metastasis, follow up time and clinical progression status 
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ÖZET
amaç
Lokalize prostat kanseri nedeniyle radikal prostatektomi yapılan hastalarda 
cerrahi sınır pozitifliğini öngörecek parametreleri analiz etmek.
gereç ve yöntem
Bu çok merkezli çalışmada, 1993-2011 yılları arasında Türkiye’deki 12 farklı 
klinikte lokalize prostat kanseri nedeniyle radikal prostatektomi uygulanan 
1607 hastanın verileri değerlendirildi. Neoadjuvan tedavi alan hastalar 
çalışmaya dahil edilmedi. Radikal prostatektomi sonrası cerrahi sınır durumu 
ile ilişkili olabilecek yaş, kanser özellikleri, transüretral prostat rezeksiyonu 
öyküsü, cerahi deneyim ve sinir koruyucu teknik gibi potansiyel öngörücü 
faktörler arasındaki ilişki tekli ve çoklu Cox regresyon analizi ve T-test 
kullanılarak değerlendirildi.
Bulgular
Tüm cerrahi sınır pozitiflik oranı %22,6 (359 hasta) olarak bulunmuştur. 
Tekli analizlerde, preoperatif prostat spesifik antijen seviyesi, klinik evre, 
biyopsideki Gleason skoru, biyopsi spesmenindeki kanser yüzdesi, transüretral 
prostat rezeksiyonu öyküsü, cerrahi deneyim ve sinir koruyucu teknik 
uygulaması pozitif cerrahi sınır oranı ile anlamlı olarak ilişkili bulunmuştur. 
Çoklu analizlerde ise preoperatif prostat spesifik antijen seviyesi (OR: 1,03, 
p=0,06), biyopsi spesmenindeki kanser yüzdesi (OR: 7,14, p<0,001), cerrahi 
deneyim (OR: 2,35, p=0,011) ve tek taraflı sinir koruyucu teknik uygulanması 
(OR: 1,81, p=0,018) cerrahi sınır pozitifliği için bağımsız öngörüsel faktörler 
olarak tespit edilmiştir.
Sonuç
Lokalize prostat kanseri nedeniyle radikal prostatektomi uygulanan 
hastalarda, preoperatif prostat spesifik antijen seviyesi, biyopsi spesmenindeki 
kanser yüzdesi, cerrahi deneyim ve sinir koruyucu teknik uygulaması cerrahi 
sınır pozitifliği öngören en önemli faktörlerdir.
anahtar Kelimeler
Prostat kanseri, radikal prostatektomi, cerrahi sınır, PSA, tümör tutulum 
yüzdesi, cerrahi deneyim, sinir koruyucu teknik
ABSTRACT
objective 
To analyze the parameters that predict the surgical margin positivity after 
radical prostatectomy for localized prostate cancer.
Materials and Methods
In this multicenter study, the data of 1607 consecutive patients undergoing 
radical prostatectomy for localized prostate cancer in 12 different clinics in 
Turkey between 1993-2011 were assessed. Patients who had neoadjuvant 
treatment were excluded. We assessed the relationship between potential 
predictive factors and surgical margin status after radical prostatectomy 
such as age, cancer characteristics, history of transurethral prostate resection, 
surgical experience and nerve-sparing technique by using univariate and 
multivariate Cox regression analyses and t test.
Results
The overall surgical margin positivity rate was 22.6% (359 patients). In 
univariate analyses, preoperative prostate specific antigen level, clinical 
stage, biopsy Gleason score, percentage of tumor involvement per biopsy 
specimen, transurethral prostate resection history, surgical experience and 
nerve-sparing technique were significantly associated with positive surgical 
margin rate. In multivariate analyses, preoperative prostate specific antigen 
level (OR: 1.03, p=0.06), percentage of tumor involvement per biopsy 
specimen (OR: 7,14, p<0,001), surgical experience (OR: 2.35, p=0.011) and 
unilateral nerve-sparing technique (OR: 1.81, p=0.018) were independent 
predictive factors for surgical margin positivity.
conclusion 
Preoperative prostate specific antigen level, percentage of tumor involvement 
per biopsy specimen, surgical experience and nerve-sparing technique are 
the most important predictive factors of surgical margin positivity in patients 
undergoing radical prostatectomy for localized prostate cancer.
Key Words
Prostate cancer, radical prostatectomy, surgical margin, PSA, percentage of 
tumor involvement, surgical experience, nerve sparing technique
Positive surgical margins after radical prostatectomy are associated with an increased hazard of biochemical recurrence, local recurrence, and the development 
of distant metastasis as well as the need for secondary cancer treatments. This is the first and single study that is analyzing the surgical margin positivity after 
radical prostatectomy and predictive factors from Turkey. Also, this study presents significant contribution to the literature with a high patient volume.
What’s known on the subject? and What does the study add?
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were recorded in a common database. Those with missing information 
of the preoperative serum PSA level, Gleason score, clinical stage 
and patients who had neoadjuvant treatment were excluded from 
analysis. All biopsy specimens were graded histologically using 
the Gleason scoring system (7). For the purposes of this study all 
participating centers agreed to record capsular penetration, status of 
surgical margins, seminal vesicle invasion and lymph node status of 
the patients according to the 1992 TNM staging system (8). Cancer 
was considered as organ confined if the capsule was not penetrated. 
The clinical staging was also done by the aid of the same staging 
system. Preoperative characteristics and the pathological findings in 
our patients were compared to a published-Johns Hopkins cohort as 
well as other validation study groups.
Statistics
All statistical evaluations were 2-sided and performed by Statistical 
Package for Social Sciences (SPSS) Version 11.0 package program. The 
impact of possible predictive factors (age, preoperative PSA value, 
clinical stage, preoperative Gleason score, positive biopsy core ratio, 
history of TURP, surgical experience, NS status) on surgical margin 
positivity after RP were assessed by univariate and multivariate Cox 
regression analysis and t test.
Results
Median age of the patients was 63 years (range, 40 to 84 years). 
Preoperative serum PSA levels ranged from 0.4 to 100 ng/ml (median, 
7.6 ng/ml). The median follow-up time was 24 months (range, 1 to 
177 months). The patient characteristics were shown in Table 1.
All patients underwent RP. A total of 1585 patients (98.6%) underwent 
open RP. Characteristics of RP were shown in Table 2. NS technique 
utilized in 656/1607 (40.8%) of the patients. Previous case loads of 
surgeons were as shown in Table 2.
The overall PSM rate was 22.6% (359/1607 of the patients). In 
univariate analysis, preoperative PSA level (p=0.000), clinical stage 
(p<0.001), biopsy Gleason score (p<0.001), percentage of cancer in the 
biopsy specimens (p<0.001), history of TUR surgery (p=0.032), surgical 
experience (p<0.001) and NS technique (p=0.006) were all associated 
with PSM status in RP (Table 3). PSM rates increased with increasing 
PSA levels, biopsy Gleason score and percentage of cancer in biopsy 
specimens (Table 3). Nevertheless, same was true for the clinical stage. 
Interestingly, patients with cT1b disease had a significantly higher 
rate of PSM (47.1%). PSM status was significantly lower in surgeons 
with an experience of >300 procedures. Bilateral NS technique had 
lower (16.6%) PSM rate compared to non or unilateral NS techniques.
In multivariate analysis, preoperative PSA level (p=0.006), percentage 
of cancer in the biopsy specimens (p<0.001), surgical experience 
(p=0.011) and NS technique (p=0.021) were significant independent 
predictor factors of PSM in RP (Table 4).
discussion
PSM after RP for prostate cancer has been shown to be associated 
with an increased risk of PSA recurrence, local recurrence, and the 
development of distant metastasis (5). Accordingly, preoperative 
prediction of surgical margin status is crucial to decide the proper 
surgical technique or necessity of neoadjuvant therapy. PSM 
depends on surgeon and his experience, surgical technique, cancer 
characteristics as well as pathological evaluation.
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table 1. Patient characteristics
Characteristics n=1607
Age, year, median (range) 63 (40-84)
Preoperative serum PSA¥ level, ng/ml, median (range) 7.6 (0.4-100)
Biopsy Gleason score, %
<7 73.4
3+4 15.5
4+3 6.1
>7 5.0
Clinical stage, %
T1a 0.4
T1b 1.1
T1c 55.5
T2a 28.8
T2b 9.1
T2c 3.9
T3 1.4
Percentage of cancer in biopsy specimens,%, median 
(range) 0.33 (0.04-1.0)
TURP§ history, % 6.7
¥: Prostate-specific antigen, §: Transurethral resection of prostate
table 2. characteristics of radical prostatectomy
Characteristics n=1607
Operation type, %
Open 98.6
Laparoscopic 1.2
Robot-assisted 0.2
Nerve-sparing, %
No 59.2
Unilateral 12.0
Bilateral 28.8
Surgeon experience, %
0-20 cases 3.3
21-50 cases 11.9
51-100 cases 18.5
101-150 cases 12.0
151-200 cases 29.4
201-250 cases 5.6
301-400 cases 10.9
>500 cases 7.5
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PSM rates were reported between 7.6% and 41.6% in the literature 
(3,4,9,10,11). Overall PSM rate in our cohort was 22.6%, which was in 
line with previous publications.
Freedland et al. examined the association between preoperative PSA 
and risk of adverse pathologic features and biochemical progression 
on 925 men with prostate cancer treated by RP within the Shared 
Equal Access Regional Cancer Hospital (SEARCH) database (12). They 
showed that higher preoperative PSA values were associated with 
increased odds of extraprostatic extension, PSM, and seminal vesicle 
invasion and increased risk of biochemical progression. Cheng et al. 
also showed that preoperative serum PSA level was independently 
associated with surgical margin status in patients who underwent 
RP for prostate cancer (13). Similarly, PSM rates had been increased 
with increasing serum PSA levels in our study. Both in univariate and 
multivariate analysis indicated, a positive association with PSA levels 
and PSM.
Wieder and Soloway reported that patients with higher preoperative 
PSA levels, biopsy Gleason score 7 and clinical stage T2b, T2c or T3 
cancer have a higher risk of positive margin (6). Ramos et al. showed 
lower PSM rates in T1c tumors compared to T2b in 1620 patients who 
underwent open RP by a single surgeon (14). Terakawa et al. showed 
that biopsy Gleason score and clinical T stage were significantly 
associated with the presence of PSM in 220 patient who underwent 
RP (15). Coelho et al. showed that the only preoperative factor 
predicting the PSM in 876 patients who underwent robot-assisted 
laparoscopic RP was clinical stage, with a higher PSM rate for T3 
versus T1c and T2 versus T1c (16). In their study biopsy Gleason grade 
was not correlated with PSM in the multivariate analysis. In our study, 
PSM rates increased with clinical stages with the-only exception of 
cT1b group (47.1%). The reason for abovementioned high PSM rate 
could be preoperative understaging and technical difficulties in the 
operation due to a former TURP. Therefore, a detailed preoperative 
staging possibly with 3T multiparametric magnetic resonans imaging 
(MRI), an extended repeat prostate biopsy-as well as very selective use 
of nerve sparing procedure cases in this group of patients. detailed 
prostate biopsy) and do nevre sparing in selected cases in this group 
of patients. 
In the present study, PSM rates had been increased with the increasing 
biopsy Gleason score-in the univariate analysis, however did not 
predict the margin status in multivariate analysis.
table 3. Univariate analysis of risk factors that predict surgical 
margin status
Margin Status
Risk Factors Negative Positive p value
Preoperative PSA¥ level 
(ng/ml)
1160 (77.5) 337 (22.5) 0.000
0-4 81 (85.3) 14 (14.7)
4.1-10 768 (84.0) 146 (16.0)
10.1-20 237 (65.5) 125 (34.5)
>20.1 74 (58.7) 52 (41.3)
Clinical stage 1229 (77.4) 358 (22.6) <0.001
T1a 4 (80.0) 1 (20.0)
T1b 9 (52.9) 8 (47.1)
T1c 722 (82.0) 158 (18.0)
T2a 344 (75.6) 111 (24.4)
T2b 84 (64.4) 52 (35.6)
T2c 44 (71.0) 18 (29.0)
T3 12 (54.5) 10 (45.5)
Biopsy Gleason score 1231 (77.5) 358 (22.5) 0.004
<7 928 (79.7) 237 (20.3)
3+4 181 (73.3) 66 (25.7)
4+3 69 (70.4) 29 (29.6)
>7 53 (67.1) 26 (32.9)
Percentage of cancer in 
biopsy specimens
789 (80.6) 190 (19.4) <0.001
0-20 291 (90.4) 31 (9.5)
21-40 286 (83.9) 55 (16.1)
41-100 212 (67.1) 104 (32.9)
TURP§ history 1066 (78.3) 296 (21.7) 0.032
No 1003 (78.9) 268 (21.1)
Yes 63 (69.2) 28 (30.8)  
Surgical experience 1078 (78.3) 299 (21.7) <0.001
0-20 36 (78.3) 10 (21.7)
21-50 129 (78.7) 35 (21.3)
51-100 178 (70.1) 76 (29.9)
101-150 138 (84.7) 25 (15.3)
151-200 295 (72.7) 111 (27.3)
201-250 65 (72.2) 25 (27.8)
301-400 142 (94.0) 9 (6.0)
>500 95 (92.2) 8 (7.8)
Nerve-sparing 1097 (75.8) 350 (24.2) 0.006
No 531 (73.9) 223 (26.1)
Unilateral 125 (71.8) 49 (28.2)
Bilateral 341 (81.4) 78 (16.6)
¥: Prostate-specific antigen, §: Transurethral resection of prostate
table 4. Multivariate analysis of the preoperative predictor 
factors of surgical margin status
Multivariate
Risk Factors OR¶ 95% CIҐ p value
Preoperative PSA¥ level 1.03 1.01-1.05 0.006
Percentage of cancer in 
biopsy specimens 15.56 7.14-33.90 <0.001
Surgical experience 2.35 1.22-4.54 0.011
Nerve-sparing 0.021
Unilateral 1.81 1.11-2.97 0.018
Bilateral 0.81 0.51-1.30 0.386
¶: Odds ratio, Ґ: Confidence interval, ¥: Prostate-specific antigen
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Cheng et al. showed that percentage of cancer in the biopsy specimens 
was independently associated with surgical margin status in patients 
who underwent RP for prostate cancer (13). Ahyai et al. also reported 
tumor volume is significantly larger in patients with a PSM than in 
those with no PSM in pT2 disease (17). In our study, PSM rate increased 
with the increasing percentage of cancer in biopsy specimens. The 
PSM rate had been increased from 9.5% in 0-20% cancer group to 
32.9% in 41-100% cancer group (Table 3). In multivariate analysis, 
percentage of cancer in the biopsy specimen was an independent risk 
factor for PSM (OR: 15.56; 95% CI, 7.14 to 33.90).
Palisaar et al. assesed the oncological outcomes of patients 
treated with open RP for prostate cancer and who had previously 
undergone TURP (18). They reported that the overall PSM rate was 
insignificantly higher in cases who had RP after TURP. However 
after 1 year of follow-up the BCR (PSA>0.04 ng/mL) did not differ 
significantly in patients who had RP after TURP vs RP alone. Jaffe et 
al. reviewed outcomes for men with a history of TURP who underwent 
laparoscopic RP for prostate cancer and reported that these patients 
have worse outcomes about PSM (19). Gupta et al. analyzed and 
compared surgical, oncological, and functional outcomes of root-
assisted laparoscopic RP in patients with and without previous TURP 
and showed that post TURP patients were found to have significantly 
greater margin positivity rates (20). In our study, in the univariate 
analysis, PSM rates were higher in patients who underwent RP after 
TURP, however in the multivariate analysis, there was no correlation 
between the PSM rates and TURP history.
Chun et al. investigated the association between surgical volume (SV) 
and the rate of PSM after RP in a large single-institution cohort of 
patients (21). They reported that patients treated by surgeons with 
a very high volume (>1000 cases) can expect to have a significantly 
lower rate of PSM. In a recent study, learning curve for surgical margins 
after open RP was assesed in a cohort included 7765 prostate cancer 
patients who were treated with RP by one of 72 surgeons at four 
major United States academic medical centers (22). In multivariable 
analysis, surgeon experience was strongly associated with surgical 
margin status. In this abovementioned study, the authors reported 
that the probability of a PSM was 40% for a surgeon with 10 prior 
cases, and decreased to 25% for a surgeon with 250 prior cases. 
Eastham et al. examined the variations in the rate of PSMs among 
surgeons after controlling for the severity of disease and volume of 
cases per surgeon (23). A total of 4629 men were treated with RP by 
1 of 44 surgeons at 2 large urban centers between 1983 and 2002 for 
clinical stage T1-T3NxM0 prostate cancer. In abovementioned study, 
multivariable analysis had been showed that, surgical volume was 
associated with surgical margin status after controlling for all other 
clinical and pathological variables. In our study, PSM rates had been 
decreased below 10% with the SV more than 300 cases. Furthermore, 
in multivariate analysis, surgeon experience is an independent factor 
for surgical margin status.
Palisaar et al. evaluated whether NS procedure itself is a risk factor for 
BCR in carefully selected patients (18). They suggested that NS RP is an 
oncologically safe procedure provided that appropriate preoperative 
selection of patients by means of a validated nomograms. Sofer et 
al. reported the results of 734 RP procedures in which 240 of them 
had NS technique (24). They suggested that in patients with localized 
prostate cancer, neither margin status nor biochemical-free survival 
within 5 years of surgery were altered by the nerve preservation 
technique. In our study, in univariate analysis, PSM rates were lower 
in patients who underwent bilateral NS RP than the patients with 
non-NS RP. This can be a result of patient selection for NS surgery. In 
multivariate analysis, unilateral NS tehnique was an independent risk 
factor for surgical margin status.
Our study has some limitations. First, we could not assess the 
relationship between the surgical technique (open, laparoscopic and 
robot-assisted) and PSM since the data of laparoscopic and robot-
assisted series were insufficient. Second, we could not evaluate the 
location of surgical margin on the radical prostatectomy specimens. 
Because this was a multicenter study and pathology specimens were 
assesed by different pathologist from different centers. 
In conclusion, parameters related to the prostate cancer, such 
as preoperative PSA level, clinical stage, biopsy Gleason score, 
percentage of positive cores, history of TURP, surgical experience and 
NS technique were all significantly associated with the PSM rates. 
Preoperative PSA level, percentage of cancer in biopsy specimens, 
surgical experience and surgical technique are independent predictive 
factors for surgical margin status in patients who underwent RP for 
prostate cancer.
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